Imaging Diagnosis of Liver Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 157
Special Issue Editor
Interests: medical imaging; diagnostic radiology; abdominal imaging; oncoradiology image analysis; radiomics; artificial intelligence elastography; MR relaxometry; multiparametric MR imaging
Special Issue Information
Dear Colleagues,
Chronic liver diseases, including hepatic steatosis and fibrosis, are a major global health concern as they affect around 1.5 billion people worldwide. Imaging studies are increasingly important in the diagnosis, classification, and follow-up of CLD. With the introduction of new imaging biomarkers into clinical practice, the objective and highly reproducible non-invasive diagnosis of CLD has become a reality. Currently, research is in progress to develop new non-invasive methods not only to quantitate pathological changes in the composition of the liver parenchyma but also to identify the causative agents and determine the activity of the underlying CLD.
One of the most rapidly developing techniques in the field is quantitative ultrasound (QUS), which has shown great promise in initial studies as a rapid, accessible, cost-effective tool for screening and follow-up CLD. Meanwhile, sophisticated imaging techniques are becoming increasingly available in cross-sectional modalities such as multiparametric MRI or spectral CT to provide highly accurate measurements of tissue composition or perfusion of the liver parenchyma. Artificial intelligence is also rapidly gaining importance for the automated evaluation of diffuse liver diseases in imaging studies.
Considering the multitude of etiologies, disease processes, and clinical management options associated with CLD, finding the best-fit imaging protocols for the different patient populations necessitates a large volume of research and excites significant interest from clinicians. The aim of this Special Issue is to reveal various aspects of research conducted in the field and to propose new imaging-based solutions for the diagnosis of CLD.
Dr. Pál Kaposi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic liver diseases
- hepatic steatosis
- fibrosis
- quantitative ultrasound
- multiparametric MRI
- spectral CT
